Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• Quality is the dimension where LLY ranks best; there it ranks ahead of 92.26% of US stocks.
• The strongest trend for LLY is in Growth, which has been heading down over the past 177 days.
• LLY's current lowest rank is in the Momentum metric (where it is better than 22.96% of US stocks).

LLY Stock Summary

• ELI LILLY & CO's market capitalization of $330,671,410,979 is ahead of 99.63% of US-listed equities.
• LLY's went public 37.1 years ago, making it older than 93.53% of listed US stocks we're tracking.
• With a price/sales ratio of 11.31, ELI LILLY & CO has a higher such ratio than 89.76% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to ELI LILLY & CO, a group of peers worth examining would be MRK, NVO, BABA, PFE, and ABBV.
• LLY's SEC filings can be seen here. And to visit ELI LILLY & CO's official web site, go to www.lilly.com.

LLY Valuation Summary

• LLY's price/sales ratio is 11.2; this is 446.34% higher than that of the median Healthcare stock.
• Over the past 243 months, LLY's price/sales ratio has gone up 4.9.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

Its year over year net cashflow from operations growth rate is now at 3.17%.
• The 4 year cash and equivalents growth rate now stands at -35.08%.
• Its 5 year revenue growth rate is now at 6.96%.

Over the past 67 months, LLY's revenue has gone up $7,654,200,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	29,239.5	7,661.2	6,033.2
2022-06-30	29,070.7	7,107.7	5,691.6
2022-03-31	29,322.8	8,062.5	6,129.3
2021-12-31	28,318.4	7,260.7	5,581.7
2021-09-30	27,758.5	6,919.4	5,972.4
2021-06-30	26,726.3	7,094.7	6,070.7

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
• LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
• BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.